Next-generation sequencing and RT-PCR to identify a 32-day SARS-CoV-2 carrier

Lingjie Song, Guibao Xiao, Ruixiang Tang, Xianqin Zhang, Zhan Gao, Shixia Sun, Lin Zhang, Youjun Feng, Guangxin Luan, Sheng Lin, Miao He, Xu JiaClinical 2021 · DOI · OpenAlex

Abstract

This case report documents a middle-aged female patient who remained a SARS-CoV-2 carrier for 32 days, repeatedly testing negative via standard RT-PCR throat swabs despite clear clinical symptoms and radiological evidence of infection. While 17 separate nucleic acid tests were performed over the course of a month, only deep sputum samples eventually yielded positive results. Next-Generation Sequencing (NGS) was employed to confirm the presence of viral genetic material in samples previously labeled negative by RT-PCR, highlighting the critical importance of sample site and detection sensitivity in identifying long-term, low-load viral carriers.

Introduction

Since the outbreak of SARS-CoV-2, RT-PCR has served as the primary diagnostic tool. However, clinicians have frequently encountered patients with classic COVID-19 symptoms and "ground-glass opacities" on CT scans who consistently return negative RT-PCR results from upper respiratory swabs. These "occult" (hidden) carriers pose a significant public health risk, as they can unknowingly spread the virus. This study investigates a specific case to understand the limitations of standard testing and the role of advanced sequencing in bridging diagnostic gaps.

Methods

The patient, a hotel worker with close contact with confirmed COVID-19 cases, was monitored over a month-long isolation period starting February 2. Diagnostic methods included:

  1. Standard RT-PCR: Targeting the N (nucleocapsid), E (envelope), and R (RdRp) genes.
  2. Chest Imaging: Longitudinal monitoring via CT scans and radiographs to track lung lesions.
  3. Next-Generation Sequencing (NGS): Deep sequencing was performed on three specific samples—two throat swabs that were negative by RT-PCR and one positive sputum sample—to detect viral reads that standard PCR might have missed.
  4. Enhanced Sampling: To improve viral yield, 3% sodium chloride atomization was used to induce the collection of "deep" sputum samples from the lower respiratory tract.

Results

Clinical and Radiological Findings

Upon admission, the patient had been coughing for more than 20 days. Despite initial negative nucleic acid tests on February 7, 8, 11, and 13, a CT scan conducted on February 15 revealed patchy ground-glass opacities in her lungs (Figure 1). This radiological evidence led clinicians to highly suspect SARS-CoV-2 infection despite the lack of molecular confirmation at the time.

Figure 1: CT scans from February 15 showing patchy ground-glass opacity (arrows), providing early clinical evidence of infection despite negative PCR results.

Molecular Detection and NGS Success

Out of 17 nucleic acid tests performed, throat swabs remained stubbornly negative or inconclusive. It was not until February 24—the ninth sputum test—that a positive RT-PCR result was obtained.

To investigate the discrepancy, NGS was performed on the "negative" throat swabs from February 22 and 23. As shown in Table 2, NGS successfully identified thousands of SARS-CoV-2 reads in these samples. Specifically, the February 22 throat swab contained 4,035 viral reads, and the February 23 swab contained 1,938 reads, proving that the virus was present even when RT-PCR failed to amplify it.

Table 2: NGS results for samples collected on February 22, 23, and 24, demonstrating viral detection in RT-PCR negative throat swabs.

Following a treatment regimen of Arbidol, chloroquine phosphate, and lopinavir/ritonavir, the patient’s lung lesions were absorbed, and she was discharged on March 12 after meeting negative testing requirements.

Discussion and Conclusion

This case highlights two critical diagnostic challenges: sample site and detection sensitivity. The virus appears to retreat to the lower respiratory tract in later stages of infection, making upper respiratory swabs (throat/nasopharyngeal) unreliable. Furthermore, standard RT-PCR has a sensitivity threshold that may miss low-load carriers.

For future clinical practice, a negative RT-PCR result should not be used in isolation to rule out COVID-19 if clinical symptoms or imaging suggest otherwise. Combining induced sputum collection with high-sensitivity methods like NGS or capture sequencing is essential for identifying and managing long-term viral carriers.

Summary updated

Abstract

To the Editor, Since the outbreak of SARS-CoV-2 in Wuhan (Hubei, China) in December 2019 [1], it has spread rapidly and has become a major public health emergency worldwide.The World Health Organization announced the official name of the disease caused by this virus as coronavirus disease 2019 .According to the "Diagnosis and Treatment of COVID-19 (Trial Version 7)", the disease must be confirmed by RT-PCR or pathogen gene sequencing from respiratory, digestive or blood samples.RT-PCR is often used for clinical detection.Recently, negative RT-PCR results have been reported for nasopharyngeal swabs of patients exhibiting COVID-19 clinical symptoms [2].Thus, it is necessary to determine the causes underlying these multiple RT-PCR negative results.We report here the case of a middle-aged woman who worked in a hotel and returned home on January 23.She had no contact with people returning from affected areas, no travel history to Wuhan and has denied any contact with wild animals.After her colleagues were diagnosed with COVID-19, she was transferred to the local county people's hospital for isolation and observation on February 2. It was later learned that about eight colleagues were diagnosed with COVID-19.The patient had been in close contact with one confirmed patient and belonged to the third or fourth generation of transmission patients [3].During intensive medical observation from February 2 to February 6, the patient showed no other clinical symptoms.The nucleic acid tests of pharyngeal swab samples were negative on February 7, 8, 11, and 13.However, CT scans (Figure 1) conducted on February 15 showed patchy ground-glass opacity in her lungs, and the patient was highly suspected of SARS-CoV-2 infection.Subsequently, the results of two RT-PCR tests were negative.To further improve the relevant examination and treatment, the patient was transferred to The First People's Hospital of Ziyang City on February 21 for further isolation and treatment.The patient had no chronic history of hypertension, diabetes, coronary heart disease, etc.At the time of admission, the patient had been coughing for more than 20 days, but dyspnea, diarrhea, and vomiting were absent.Even during hospitalization, there were no clinical symptoms such as fever, diarrhea and vomiting except coughing.Since February 7, a total of 17 SARS-CoV-2 nucleic acid tests were performed.Only sputum samples tested positive, while the rest tested negative.Nucleic acid tests were still negative on February 22 and single-target positive on February 23.Until February 24, the ninth practical sputum nucleic acid test was positive.The specific RT-PCR results and patient's symptoms are shown in Table 1.
BibTeX
@inproceedings{song2021next,
  author = {Lingjie Song and Guibao Xiao and Ruixiang Tang and Xianqin Zhang and Zhan Gao and Shixia Sun and Lin Zhang and Youjun Feng and Guangxin Luan and Sheng Lin and Miao He and Xu Jia},
  title = {{Next-generation sequencing and RT-PCR to identify a 32-day SARS-CoV-2 carrier}},
  booktitle = {Clinical},
  year = {2021},
  doi = {10.1515/cclm-2020-1629},
}
Figure